SciCross (@SciCross) profile picture
Joined October 2011
SciCross retweeted
Just published 📣using #metabolomics and #MachineLearning to identify biomarkers associated with subclinical atherosclerosis in SLE . Great collaboration and tweetorial @inespinedatorra 👇
3
7
Really happy to be part of this great collaboration. A deeper understanding of T-cell responses will give insights into protection after Covid-19 infection, as well as what we can expect after vaccination. #covid19research #SciCross #immunogenicity uu.se/en/news-media/news/art…
SciCross is attending CHI’s Immunogenicity & Bioassay Summit 2020 Oct 6-9, presenting collaborative work with Novartis on immunogenicity prediction. #ImmunoBio20 #immunogenicity @Novartis
SciCross retweeted
Early start travelling to #FOCIS 2018 San Francisco. Presenting reduced Notch2 in monocytes predicts anti drug response #MS #ABIRISK
1
3
New paper on immunogenicity risk in MS patients treated with Interferon beta published in JCI Insight, scicross.com/2018/06/16/immu…. #immunogenicity #MS #ABIRISK
4
3
New publication on on protein de-immunization, together with Harvard Medical school and the University of Tubingen. #immunogenicity #FVIII #computationalimmunology scicross.com/2018/05/02/dual…
1
1
ACR 2017, Methotrexate Requires High Serum BAFF Levels to Prevent Immunization Against TNF-α Inhibitors acrabstracts.org/abstract/me… #abirisk
New paper from the ABIRISK consortium. #eTRIKS #MS @IMI_JU dx.doi.org/10.1371/journal.p…
1
2
1
1
Not bad! #sweden #innovation These Are the World's Most Innovative Economies bloomberg.com/news/articles/… via @markets
September issue of the ABIRISK scientific newsletter published abirisk.eu/documents/newslet… #abirisk #immunogenicity @IMI_JU
Great presenations by #ABIRISK @IMI_JU members on drug #immunogenicity at #ECI2015!
1
2
Meet us at the SMi Immunogenicity conference in London, July 14-15, smi-online.co.uk/pharmaceuti…
1